Publikace

2020

Mikulenkova E, Neradil J, Vymazal O, Skoda J, Veselska R

NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation

Cells, 9 (3), 692, 2020. doi:10.3390/cells9030692

Skoda J, Neradil J, Zambo I, Nunukova A, Macsek P, Borankova K, Dobrotkova V, Nemec P, Sterba J, Veselska R

Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells

Cancers, 12 (1), 196, 2020. doi:10.3390/cancers12010196

Krchniakova M, Skoda J, Neradil J, Chlapek P, Veselska R

Repurposing tyrosine kinase inhibitors to overcome multidrug resistance in cancer: A focus on transporters and lysosomal sequestration

International Journal of Molecular Sciences, 21 (9), 2020. doi:10.3390/ijms21093157

Polaskova K, Merta T, Martincekova A, Zapletalova D, Kyr M, Mazanek P, Krenova Z, Mudry P, Jezova M, Tuma J, Skotakova J, Cervinkova I, Valik D, Zdrazilova-Dubska L, Noskova H, Pal K, Slaby O, Fabian P, Kozakova S, Neradil J, Veselska R, Kanderova V, Hrusak O, Freiberger T, Klement G L, Sterba J

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside

Frontiers in Oncology, 9 , 2020. doi:10.3389/fonc.2019.01531

Gojo J, Pavelka Z, Zapletalova D, Schmook M T, Mayr L, Madlener S, Kyr M, Vejmelkova K, Smrcka M, Czech T, Dorfer C, Skotakova J, Azizi A A, Chocholous M, Reisinger D, Lastovicka D, Valik D, Haberler C, Peyrl A, Noskova H, Pál K, Jezova M, Veselska R, Kozakova S, Slaby O, Slavc I, Sterba J

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities

Frontiers in Oncology, 9 , 2020. doi:10.3389/fonc.2019.01436

2019

Dobrotkova V, Chlapek P, Jezova M, Adamkova K, Mazanek P, Sterba J, Veselska R

Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers

PLoS One, 14 (6), e0218269, 2019. doi:10.1371/journal.pone.0218269

Gomes S, Raimundo L, Soares J, Loureiro J B, Leao M, Ramos H, Monteiro M N, Lemos A, Moreira J, Pinto M, Chlapek P, Veselska R, Sousa E, Saraiva L

New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma

Cancer Lett, 446 , 90-102, 2019. doi:10.1016/j.canlet.2019.01.014

Kyr M, Polaskova K, Kuttnerova Z, Merta T, Neradil J, Berkovcova J, Horky O, Jezova M, Veselska R, Klement G L, Valik D, Sterba J

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario

Front Oncol, 9 , 644, 2019. doi:10.3389/fonc.2019.00644

Neradil J, Kyr M, Polaskova K, Kren L, Macigova P, Skoda J, Sterba J, Veselska R

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology

Front Oncol, 9 , 930, 2019. doi:10.3389/fonc.2019.00930

Skoda J, Borankova K, Jansson P J, Huang M L, Veselska R, Richardson D R

Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies

Pharmacol Res, 139 , 298-313, 2019. doi:10.1016/j.phrs.2018.11.020

Veselska R, Jezova M, Kyr M, Mazanek P, Chlapek P, Dobrotkova V, Sterba J

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy

Front Oncol, 9 , 1221, 2019. doi:10.3389/fonc.2019.01221

2018

Dobrotkova V, Chlapek P, Mazanek P, Sterba J, Veselska R

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

BMC Cancer, 18 (1), 1059, 2018. doi:10.1186/s12885-018-4966-5

Chlapek P, Slavikova V, Mazanek P, Sterba J, Veselska R

Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids

Int J Mol Sci, 19 (1), 2018. doi:10.3390/ijms19010132

Skoda J, Veselska R

Cancer stem cells in sarcomas: Getting to the stemness core

Biochim Biophys Acta Gen Subj, 1862 (10), 2134-2139, 2018. doi:10.1016/j.bbagen.2018.07.006

Sramek M, Neradil J, Macigova P, Mudry P, Polaskova K, Slaby O, Noskova H, Sterba J, Veselska R

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis

Int J Mol Sci, 19 (9), 2018. doi:10.3390/ijms19092599

2017

Chlapek P, Zitterbart K, Kren L, Filipova L, Sterba J, Veselska R

Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups

PLoS One, 12 (2), e0172552, 2017. doi:10.1371/journal.pone.0172552

Mudry P, Slaby O, Neradil J, Soukalova J, Melicharkova K, Rohleder O, Jezova M, Seehofnerova A, Michu E, Veselska R, Sterba J

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene

BMC Cancer, 17 (1), 119, 2017. doi:10.1186/s12885-017-3115-x

Sramek M, Neradil J, Veselska R

Much more than you expected: The non-DHFR-mediated effects of methotrexate

Biochim Biophys Acta Gen Subj, 1861 (3), 499-503, 2017. doi:10.1016/j.bbagen.2016.12.014

2016

Skoda J, Hermanova M, Loja T, Nemec P, Neradil J, Karasek P, Veselska R

Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma

PLOS ONE, 11 (7), 2016. doi:10.1371/journal.pone.0159255

Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Mudry P, Zitterbart K, Hermanova M, Hampl A, Sterba J, Veselska R

Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice

TUMOR BIOLOGY, 37 (7), 9535-9548, 2016. doi:10.1007/s13277-016-4837-0

Sramek M, Neradil J, Sterba J, Veselska R

Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation

CANCER CELL INTERNATIONAL, 16 , 2016. doi:10.1186/s12935-016-0289-2

Chlapek P, Slavikova V, Sterba J, Veselska R

Sensitivity to the natural and synthetic retinoids in relation to the expression of selected protein markers in neuroblastoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 38 (1), S55, 2016.

Neradil J, Melicharkova K, Mudry P, Veselska R, Sterba J

Detailed analysis of phosphorylated receptor tyrosine kinases and downstream signaling pathways in selected pediatric malignancies

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 38 (1), S55, 2016.

Veselska R, Nunukova A, Skoda J, Loja T, Zambo I, Neradil J, Hermanova M, Hampl A, Sterba J

Tumorigenicity and expression of the core stem cell markers in rhabdomyosarcoma cells

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 38 (1), S54, 2016.

Zambo I, Hermanova M, Zapletalova D, Skoda J, Mudry P, Kyr M, Zitterbart K, Sterba J, Veselska R

Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas

CANCER BIOMARKERS, 17 (1), 107-116, 2016. doi:10.3233/CBM-160623

2015

Neradil J, Sramek M, Mrkvicova M, Zitterbart K, Sterba J, Veselska R

METHOTREXATE AND ALL-TRANS RETINOIC ACID COMBINED TREATMENT FOR INDUCTION OF OSTEOSARCOMA CELL LINES DIFFERENTIATION IN VITRO

PEDIATRIC BLOOD & CANCER, 62 (4), S268, 2015.

Skoda J, Neradil J, Zambo I, Hermanova M, Sterba J, Veselska R

IDENTIFICATION OF CANCER STEM CELLS IN OSTEOSARCOMA CELL LINES: CHARACTERIZATION OF CANCER STEM CELL MARKERS EXPRESSION AND IN VIVO TUMORIGENICITY

PEDIATRIC BLOOD & CANCER, 62 (4), S269, 2015.

Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R

METHOTREXATE INDUCES EPIGENETIC ALTERATIONS IN OSTEOSARCOMA CELL LINES

PEDIATRIC BLOOD & CANCER, 62 (4), S269, 2015.

Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R

Overexpression of the Delta Np73 isoform is associated with centrosome amplification in brain tumor cell lines

TUMOR BIOLOGY, 36 (10), 7483-7491, 2015. doi:10.1007/s13277-015-3474-3

Neradil J, Veselska R

Nestin as a marker of cancer stem cells

CANCER SCIENCE, 106 (7), 803-811, 2015. doi:10.1111/cas.12691

Nunukova A, Neradil J, Skoda J, Jaros J, Hampl A, Sterba J, Veselska R

Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36 (1), 65-72, 2015. doi:10.3892/ijmm.2015.2210

Neradil J, Pavlasova G, Sramek M, Kyr M, Veselska R, Sterba J

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines

ONCOLOGY REPORTS, 33 (5), 2169-2175, 2015. doi:10.3892/or.2015.3819

Veselska R, Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Hermanova M, Mudry P, Zitterbart K, Zapletalove D, Kyr M, Jaros J, Hamp A, Sterba J

Cancer stem cell markers in pediatric sarcomas: Comparative analysis of their expression in tumor tissues and derived cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36 (1), S71, 2015.

2014

Krzyzankova M, Chovanova S, Chlapek P, Radsetoulal M, Neradil J, Zitterbart K, Sterba J, Veselska R

LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines

TUMOR BIOLOGY, 35 (8), 7617-7627, 2014. doi:10.1007/s13277-014-2019-5

Chlapek P, Neradil J, Redova M, Zitterbart K, Sterba J, Veselska R

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression

CANCER CELL INTERNATIONAL, 14 , 2014. doi:10.1186/1475-2867-14-51

Neradil J, Veselska R, Mudry P, Melicharkova K, Sterba J

Mapping of receptor tyrosine kinases activation and downstream signaling in rhabdomyosarcoma

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 34 (1), S78, 2014.

Skoda J, Neradil J, Zitterbart K, Sterba J, Veselska R

EGFR signaling in glioblastoma cells with a loss of EGFR gene copy and unusually mild clinical course of disease

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 34 (1), S78, 2014.

Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R

Methotrexate-dependent changes of DNA methylation and gene expression in osteosarcoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 34 (1), S79, 2014.

Veselska R, Nunukova A, Skoda J, Neradil J, Jaros J, Hermanova M, Zambo I, Mudry P, Zitterbart K, Hampl A, Sterba J

Nuclear localization of CD133 in sarcoma cells

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 34 (1), S81, 2014.

Skoda J, Neradil J, Zitterbart K, Sterba J, Veselska R

EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy

ONCOLOGY REPORTS, 31 (1), 480-487, 2014. doi:10.3892/or.2013.2864

2013

Veselska R, Neradil J, Nekulova M, Dobrucka L, Vojtesek B, Sterba J, Zitterbart K

Intracellular distribution of the Delta Np73 protein isoform in medulloblastoma cells: a study with newly generated rabbit polyclonal antibodies

HISTOLOGY AND HISTOPATHOLOGY, 28 (7), 913-924, 2013.

Chlapek P, Filipova L, Zitterbart K, Sterba J, Veselska R

Medulloblastoma subcategories as identified by molecular markers differ in tumor tissue and in corresponding cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 32 (1), S39, 2013.

Neradil J, Kockova H, Zambo I, Hermanova M, Husek K, Mudry P, Zitterbart K, Sterba J, Veselska R

CXCR4 expression in sarcoma derived cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 32 (1), S39, 2013.

Veselska R, Mikulenkova E, Neradil J, Zitterbart K, Sterba J

Expression of deltaNp73 isoform and its association with centrosome amplification in neurogenic tumor cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 32 (1), S42, 2013.

2012

Veselska R, Zambo I, Skoda J, Hermanova M, Neradil J, Sana J, Chlapek P, Zitterbart K, Mudry P, Hamp A, Sterba J

Expression of CD133 and nestin in sarcomas

TUMOR BIOLOGY, 33 (1), 20, 2012, (40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, ISRAEL, OCT 13-17, 2012).

Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R

COMBAT in vitro: Enhancement of the retinoid-induced cell differentiation by LOX/COX inhibitors in cell lines derived from pediatric solid tumors

TUMOR BIOLOGY, 33 (1), 102, 2012, (40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, ISRAEL, OCT 13-17, 2012).

Zambo I, Hermanova M, Krakorova A D, Mudry P, Zitterbart K, Kyr M, Vesely K, Sterba J, Veselska R

Analysis of Nestin expression in pediatric and adult cases of high-grade osteosarcoma

VIRCHOWS ARCHIV, 461 (1), S136, 2012.

Zambo I, Hermanova M, Krakorova D, Mudry P, Zitterbart K, Kyr M, Vesely K, Sterba J, Veselska R

Nestin expression in high-grade osteosarcomas and its clinical significance

ONCOLOGY REPORTS, 27 (5), 1592-1598, 2012. doi:10.3892/or.2012.1687

2011

Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M

Clinicopathological Correlations of Nestin Expression in Surgically Resectable Pancreatic Cancer Including an Analysis of Perineural Invasion

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 20 (4), 389-396, 2011.

Zitterbart K, Dobrucka L, Chlapek P, Neradil J, Skoda J, Sterba J, Veselska R

N-TERMINAL P73 PROTEIN ISOFORMS IN MEDULLOBLASTOMA CELLS AND THEIR INVOLVEMENT IN RETINOIC ACID-INDUCED DIFFERENTIATION

PEDIATRIC BLOOD & CANCER, 57 (5), 807, 2011.

Hermanova M, Zambo I, Sana J, Skoda J, Neradil J, Chlapek P, Mudry P, Vasikova A, Zitterbart K, Sterba J, Veselska R

Identification of cells with cancer stem cell phenotype in rhabdomyosarcoma

VIRCHOWS ARCHIV, 459 (1), S316-S317, 2011.

Krupkova J, Loja T, Redova M, Neradil J, Zitterbart K, Sterba J, Veselska R

Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors

TUMOR BIOLOGY, 32 (4), 631-639, 2011. doi:10.1007/s13277-011-0162-9

Zitterbart K, Filkova H, Tomasikova L, Necesalova E, Zambo I, Kantorova D, Slamova I, Vranova V, Zezulkova D, Pesakova M, Pavelka Z, Veselska R, Kuglik P, Sterba J

Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma

JOURNAL OF NEURO-ONCOLOGY, 102 (1), 25-33, 2011. doi:10.1007/s11060-010-0289-3

Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R

Changes in gene expression in neuroblastoma and medulloblastoma cell lines during induced differentiation by combined treatment with all-trans retinoic acid and LOX/COX inhibitors

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 28 (1), S13, 2011.

Skoda J, Neradil J, Loja T, Zitterbart K, Pavelka Z, Brichtova E, Smardova J, Valaskova I, Hermanova M, Sterba J, Veselska R

Analysis of HGG-02 cell line with loss of EGFR gene copy derived from childhood glioblastoma multiforme

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 28 (1), S36, 2011.

Veselska R, Zitterbart K, Nekulova M, Dobrucka L, Neradil J, Chlapek P, Sterba J

Intracellular distribution of N-terminal isoforms of the p73 protein in medulloblastoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 28 (1), S50, 2011.

Sana J, Zambo I, Skoda J, Neradil J, Chlapek P, Hermanova M, Mudry P, Vasikova A, Zitterbart K, Hampl A, Sterba J, Veselska R

CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines

ANALYTICAL CELLULAR PATHOLOGY, 34 (6), 303-318, 2011. doi:10.3233/ACP-2011-0018

2010

Nekulova M, Zitterbart K, Sterba J, Veselska R

Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and Delta Np73 in medulloblastoma cell lines

JOURNAL OF MOLECULAR HISTOLOGY, 41 (4-5), 267-275, 2010. doi:10.1007/s10735-010-9288-0

Veselska R, Skoda J, Loja T, Zitterbart K, Pavelka Z, Smardova J, Valaskova I, Hermanova M, Sterba J

An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line

CHILDS NERVOUS SYSTEM, 26 (6), 841-846, 2010. doi:10.1007/s00381-010-1110-5

Zitterbart K, Nekulova M, Sterba J, Veselska R

INTRACELLULAR LOCALIZATION OF TAP73 AND Delta NP73 PROTEIN ISOFORMS IN MEDULLOBLASTOMA CELL LINES

NEURO-ONCOLOGY, 12 (6), II51, 2010, (14th International Symposium on Pediatric Neuro-Oncology, Vienna, AUSTRIA, JUN 20-23, 2010).

Chlapek P, Redova M, Zitterbart K, Hermanova M, Sterba J, Veselska R

Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 29 , 2010. doi:10.1186/1756-9966-29-45

Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R

Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 25 (2), 271-280, 2010. doi:10.3892/ijmm_00000341

Chlapek P, Redova M, Zitterbart K, Hermanova M, Sterba J, Veselska R

Expression profiling of neuroblastoma and medulloblastoma cell lines after combined treatment by all-trans retinoic acid and LOX/COX inhibitors

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 26 (1), S39, 2010.

Veselska R, Redova M, Chlapek P, Zitterbart K, Hermanova M, Sterba J

Enhancement of retinoid-induced cell differentiation in cancer therapy

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 26 (1), S38, 2010.

Krupkova J O, Loja T, Zambo I, Veselska R

Nestin expression in human tumors and tumor cell lines. Minireview

NEOPLASMA, 57 (4), 291-298, 2010. doi:10.4149/neo_2010_04_291

2009

Filkova H, Zitterbart K, Tomasikova L, Vranova V, Zezulkova D, Kantorova D, Kuglik P, Pavelka Z, Sterba J, Veselska R

Prognostic signification of copy number changes of MYCN and MYCC genes studied by I-FISH method in childhood medulloblastoma

CHROMOSOME RESEARCH, 17 (1), 124, 2009, (7th European Cytogenetics Conference, Stockholm, SWEDEN, JUL 04-07, 2009).

Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R

LOX/COX inhibitors: possible way to potentiate the antineoplastic effect of retinoids in neuroblastoma and medulloblastoma cell lines

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 24 , S33, 2009.

Veselska R, Hermanova M, Sana J, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J

Cancer stem cell markers in selected childhood tumors of mesenchymal origin

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 24 , S37, 2009.

Zitterbart K, Kantorova D, Filkova H, Zezulkova D, Necesalova E, Slamova I, Vranova V, Tomasikova L, Pesakova M, Oltova A, Pavelka Z, Sterba J, Kuglik P, Veselska R

Copy number changes of MYCC and MYCN genes detected by I-FISH are useful prognostic markers in children with medulloblastoma: a study from the University Hospital Brno

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 24 , S37, 2009.

Loja T, Chlapek P, Kuglik P, Pesakova M, Oltova A, Cejpek P, Veselska R

Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin

ONCOLOGY REPORTS, 21 (1), 119-127, 2009. doi:10.3892/or_00000198

2008

Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines

BMC CANCER, 8 , 2008. doi:10.1186/1471-2407-8-300

2007

Vranova V, Necesalova E, Kuglik P, Cejpek P, Pesakova M, Budinska E, Relichova J, Veselska R

Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization

ONCOLOGY REPORTS, 17 (2), 457-464, 2007.

Loja T, Kuglik P, Oltova A, Smuharova P, Zitterbart K, Bajciova V, Veselska R

The optimization of sample treatment for spectral karyotyping with applications for human tumour cells

CYTOGENETIC AND GENOME RESEARCH, 116 (3), 186-193, 2007. doi:10.1159/000098185

Necesalova E, Vranova V, Kuglik P, Cejpek P, Jarosova M, Pesakova M, Relichova J, Veselska R

Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology

NEOPLASMA, 54 (3), 212-218, 2007.

Cejpek P, Kuglik P, Veselska R, Necesalova E, Vranova V, Krupa P, Relichova J, Horky J, Vnencak P

Significance of molecular cytogenetic characterization of glioblastoma

PROCEEDINGS OF THE 13TH EUROPEAN CONGRESS OF NEUROSURGERY, 401-405, 2007, ISBN: 978-88-7587-385-1, (13th European Congress of Neurosurgery, Glasgow, SCOTLAND, SEP 02-07, 2007).

2006

Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T, Relichova J

Nestin expression in the cell lines derived from glioblastoma multiforme

BMC CANCER, 6 , 2006. doi:10.1186/1471-2407-6-32

2005

Neradil J, Veselska R, Svoboda A

The role of actin in the apoptotic cell death of P19 embryonal carcinoma cells

INTERNATIONAL JOURNAL OF ONCOLOGY, 27 (4), 1013-1021, 2005.

2004

Veselska R, Zitterbart K, Auer J, Neradil J

Differentiation of HL-60 myeloid leukemia cells induced by all-trans retinoic acid is enhanced in combination with caffeic acid

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 14 (2), 305-310, 2004.

2003

Veselska R, Zitterbart K, Jelinkova S, Neradil J, Svoboda A

Specific cytoskeleton changes during apoptosis accompanying induced differentiation of HL-60 myeloid leukemia cells

ONCOLOGY REPORTS, 10 (4), 1049-1058, 2003.

Neradil J, Veselska R, Slanina J

UVC-protective effect of caffeic acid on normal and transformed human skin cells in vitro

FOLIA BIOLOGICA, 49 (5), 197-202, 2003.

2001

Veselska R, Janisch R

Reaction of the skin fibroblast cytoskeleton to micromanipulation interventions

JOURNAL OF STRUCTURAL BIOLOGY, 136 (2), 110-118, 2001. doi:10.1006/jsbi.2001.4432

Zitterbart K, Veselska R

Effect of retinoic acid on the actin cytoskeleton in HL-60 cells

NEOPLASMA, 48 (6), 456-461, 2001.